The design and synthesis of potent, tripeptidic acylsulfonamide inhibitors of HCV NS3 protease that contain a difluoromethyl cyclopropyl amino acid at P1 are described. A cocrystal structure of with a NS3/4A protease complex suggests the presence of a H-bond between the polarized C-H of the CHF moiety and the backbone carbonyl of Leu135 of the enzyme. Structure-activity relationship studies indicate that this H-bond enhances enzyme inhibitory potency by 13- and 17-fold compared to the CH and CF analogues, respectively, providing insight into the deployment of this unique amino acid.